Neonatal screening programmes are used to detect serious congenital diseases so they can be treated early and thus prevent significant sequelae.
The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personaliz1
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1
As one of its many initiatives, the Diabetes Unit is implementing a scorecard to segment patients with diabetes and offer more efficient treatment at1
A multidisciplinary team of researchers from the Hospital Clínic Barcelona-IDIBAPS-UB, coordinated by Carolina García-Vidal and Pedro Puerta of the H1
Rapid reporting of the results of a microbiological examination for an infection is as important as having rapid diagnostic technologies to detect it.
The US Food and Drug Administration (FDA) has approved the first faecal microbiota-derived product for the treatment of infection with Clostridioides1
The Hospital Clínic has the only laboratory where the analysis of the samples from the Catalan Neonatal Screening Programme is centralized, in order1
His achievements and career path in the field of Biochemistry and Molecular Genetics led the Board of Directors to grant him this award. The commemor1
A study by the hospital Clínic Barcelona-IDIBAPS, published in the journal Neurology, confirms the usefulness of a blood-based biomarker to diagnose1
